1) Adnet F, Borron SW, Vicaut E, Giraudeaux V, Lapostolle F, Bekka R et al. Value of C-reactive protein in the detection of bacterial contamination at the time of presentation in drug-induced aspiration pneumonia. Chest 1997; 112(2):466-471. 2) Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998; 24(10):1052-1056. 3) Clarke DE, Kimelman J, Raffin TA. The evaluation of fever in the intensive care unit. Chest 1991; 100(1):213-220. 4) Arbo MJ, Fine MJ, Hanusa BH, Sefcik T, Kapoor WN. Fever of nosocomial origin: etiology, risk factors, and outcomes. Am J Med 1993; 95(5):505-512. 5) Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101(6):1644-1655. 6) Dale DC, Fauci AS, Guerry D, IV, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest 1975; 56(4):808-813. 7) Seebach JD, Morant R, Ruegg R, Seifert B, Fehr J. The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease. Am J Clin Pathol 1997; 107(5):582-591.
Referências Bibliográficas